Horizon Pharma plc Indenture Agreements
18 Contracts & Agreements
- Third Supplemental Indenture, dated March 15, 2021, by and between Viela Bio, Inc. and U.S. Bank National Association (Filed With SEC on May 5, 2021)
- Second Supplemental Indenture, dated April 23, 2020, by and among Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on May 6, 2020)
- First Supplemental Indenture, dated November 19, 2019, by and between HZNP Finance Limited and U.S. Bank National Association (Filed With SEC on May 6, 2020)
- Indenture dated as of July 16, 2019 by and between Horizon Pharma USA, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee (Filed With SEC on July 16, 2019)
- Seventh Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)
- Third Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)
- Sixth Supplemental Indenture, dated October 31, 2018, by and between Horizon Pharma USA, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Fifth Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Fourth Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Third Supplemental Indenture, dated October 25, 2016, by and among Horizon Pharmaceutical LLC, Horizon Orphan LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Second Supplemental Indenture, dated May 10, 2016, by and between Horizon Pharma Rheumatology LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- Second Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- First Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association (Filed With SEC on November 7, 2018)
- HORIZON PHARMA, INC. and HORIZONPHARMA USA, INC. 8.750% SENIOR NOTES DUE 2024 INDENTURE Dated as of October 25, 2016 U.S. BANKNATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS (Filed With SEC on October 25, 2016)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on May 11, 2015)
- HORIZON PHARMA FINANCING INC. 6.625% SENIOR NOTES DUE 2023 INDENTURE Dated as of April 29, 2015 U.S. BANKNATIONAL ASSOCIATION, Trustee TABLE OF CONTENTS (Filed With SEC on April 29, 2015)
- HORIZONPHARMA INVESTMENT LIMITED, as Issuer HORIZON PHARMA PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONALASSOCIATION, as Trustee Indenture Dated as ofMarch 13, 2015... (Filed With SEC on March 13, 2015)
- HORIZON PHARMA, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2013 5.00% Convertible Senior Notes due 2018 TABLE OF CONTENTS (Filed With SEC on November 25, 2013)
